华大智造1月30日获融资买入3783.84万元，融资余额4.65亿元

Core Viewpoint - 华大智造's stock experienced a decline of 3.37% on January 30, with a trading volume of 347 million yuan, indicating market volatility and investor sentiment towards the company [1]. Financing and Trading Data - On January 30, 华大智造 had a financing buy amount of 37.84 million yuan and a financing repayment of 21.48 million yuan, resulting in a net financing buy of 16.36 million yuan [1]. - As of January 30, the total financing and securities balance for 华大智造 was 469 million yuan, with the financing balance accounting for 1.72% of the circulating market value, indicating a high level compared to the past year [1]. - The company had a securities lending balance of 3.68 million yuan, with a remaining quantity of 56,600 shares, which is low compared to the 20th percentile over the past year [1]. Company Overview - 华大智造, established on April 13, 2016, and listed on September 9, 2022, is located in Shenzhen, Guangdong Province, focusing on life sciences and biotechnology [1]. - The company's main business revenue composition includes 90.89% from the sale of instruments, reagents, and consumables, 7.10% from services, and 2.01% from other sources [1]. Shareholder and Financial Performance - As of September 30, the number of shareholders for 华大智造 increased by 14.17% to 15,400, with an average of 26,794 circulating shares per person, up by 69.94% [2]. - For the period from January to September 2025, 华大智造 reported an operating income of 1.869 billion yuan, a slight decrease of 0.01% year-on-year, while the net profit attributable to shareholders was -120 million yuan, reflecting a significant increase of 74.20% year-on-year [2]. - The company has distributed a total of 150 million yuan in dividends since its A-share listing [3]. Institutional Holdings - As of September 30, 2025, major institutional shareholders include 易方达上证科创板50ETF, holding 7.5258 million shares, a decrease of 1.0979 million shares from the previous period [3]. - 华夏上证科创板50成份ETF and 华宝中证医疗ETF also saw reductions in their holdings, indicating potential shifts in institutional investment strategies [3].